http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2020296179-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad20e68e485d7ccee74a75669ba5fb71
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-16
filingDate 2020-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3228d95641c6ade230a5fda073d0999d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2f8c9c2791bb73c5aff537483c1d26e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d4d491e285f57ddf8836c7adce47c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5341131c092747db832c7027d6151792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_786b33020e3998a3d9148c4a094ef5a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e3202eaacd07620dd9ca670282acb93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbf8098a18fe592228415c6de425f460
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ef7ebba96a0707f0240445520110087
publicationDate 2022-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2020296179-A1
titleOfInvention Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome
abstract Provided herein are methods for using 5-azacytidine in combination with additional agents to treat diseases and disorders including AML.
priorityDate 2019-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411675801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422454219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9829523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49803313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413538397

Total number of triples: 45.